Hyzaar Extra Forte (Losartan Potassium, Hydrochlorothiazide)

Losartan potassium blocks the angiotensin II type 1 (AT₁) receptors located on vascular smooth‑muscle and adrenal cells. By preventing angiotensin II from binding, it inhibits vasoconstriction and aldosterone‑mediated sodium retention, leading to relaxation of blood vessels and reduced fluid volume. This action lowers systemic vascular resistance and helps control high blood pressure.

The appropriate dose of Hyzaar Extra Forte is individualized by the prescribing healthcare professional. Factors such as the patient’s baseline blood‑pressure level, renal function, concomitant medications, and response to therapy guide dose selection and any subsequent adjustments. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Hyzaar Extra Forte is generally not recommended during pregnancy, especially in the second and third trimesters, because angiotensin‑II receptor blockers can affect fetal development. Use during breastfeeding is also discouraged unless the benefit outweighs the potential risk to the infant. Clinicians should discuss alternative antihypertensive options with pregnant or nursing patients.

To place an order, submit an enquiry on the Hyzaar Extra Forte product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details and assists with any required import documentation.

Compared with single‑agent therapies, Hyzaar Extra Forte offers the convenience of two complementary mechanisms in one tablet, often achieving better blood‑pressure control than either an ARB or a thiazide alone. Relative to other combination products, its losartan component provides a favorable side‑effect profile, while the hydrochlorothiazide dose contributes effective diuresis. Choice depends on individual patient characteristics and tolerability.

Hyzaar Extra Forte tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and avoid storing in bathrooms or other humid environments. Do not use the medication after the expiry date printed on the packaging.

Hyzaar Extra Forte is taken orally, usually once daily, with or without food, as directed by the prescriber. The tablet should be swallowed whole with a full glass of water. Patients should not crush, chew, or split the tablet unless specifically instructed, and they should maintain consistent timing each day to ensure stable blood‑pressure control.

The most serious risks include severe allergic reactions such as anaphylaxis, acute kidney injury, and significant electrolyte disturbances like hyperkalemia or severe hyponatremia. These events require immediate medical attention. Regular monitoring of renal function and electrolyte levels helps detect problems early and reduce the likelihood of serious complications.

Hyzaar Extra Forte is contraindicated in patients with known hypersensitivity to losartan, hydrochlorothiazide, or any component of the formulation. It should also be avoided in individuals with severe renal impairment, anuria, or those taking other potassium‑sparing agents that could cause dangerous hyperkalemia. Pregnant women, especially in later trimesters, should not use the product unless no safer alternative is available.